Ulrich Dührsen
0000-0002-4034-9472
University Hospital Essen
6 papers found
Refreshing results…
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma
Efficacy of the GMALL‐B‐ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non‐Hodgkin‐lymphomas with or without CNS involvement
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
Rituximab maintenance therapy of follicular lymphoma in clinical practice
Missing publications? Search for publications with a matching author name.